SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 328 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,039,212,272 | +6.4% | 8,572,944 | +0.5% | 0.03% | +13.0% |
| Q2 2023 | $977,024,976 | -12.6% | 8,531,479 | +5.2% | 0.02% | -17.9% |
| Q1 2023 | $1,118,209,828 | +7.4% | 8,112,964 | +1.0% | 0.03% | 0.0% |
| Q4 2022 | $1,040,950,349 | +16.5% | 8,033,264 | -0.6% | 0.03% | +7.7% |
| Q3 2022 | $893,773,000 | +41.6% | 8,085,517 | -4.0% | 0.03% | +44.4% |
| Q2 2022 | $631,166,000 | -2.8% | 8,420,047 | +1.3% | 0.02% | +20.0% |
| Q1 2022 | $649,582,000 | -13.2% | 8,315,182 | +0.0% | 0.02% | -11.8% |
| Q4 2021 | $748,416,000 | +8.2% | 8,311,108 | +11.1% | 0.02% | 0.0% |
| Q3 2021 | $691,811,000 | +19.3% | 7,480,651 | +0.3% | 0.02% | +21.4% |
| Q2 2021 | $579,661,000 | +5.6% | 7,456,402 | +1.2% | 0.01% | -6.7% |
| Q1 2021 | $548,996,000 | -55.4% | 7,366,100 | +2.1% | 0.02% | -58.3% |
| Q4 2020 | $1,230,471,000 | +23.6% | 7,217,258 | +1.8% | 0.04% | +9.1% |
| Q3 2020 | $995,814,000 | -12.7% | 7,091,182 | -0.4% | 0.03% | -17.5% |
| Q2 2020 | $1,141,251,000 | +78.3% | 7,117,697 | +8.8% | 0.04% | +48.1% |
| Q1 2020 | $640,211,000 | -22.3% | 6,544,789 | +2.5% | 0.03% | -3.6% |
| Q4 2019 | $823,893,000 | +71.8% | 6,384,788 | +0.3% | 0.03% | +55.6% |
| Q3 2019 | $479,429,000 | -49.4% | 6,365,230 | +2.1% | 0.02% | -50.0% |
| Q2 2019 | $947,017,000 | +32.4% | 6,232,424 | +3.9% | 0.04% | +28.6% |
| Q1 2019 | $715,101,000 | +11.7% | 5,999,672 | +2.3% | 0.03% | -3.4% |
| Q4 2018 | $640,082,000 | -26.4% | 5,865,323 | +8.9% | 0.03% | -14.7% |
| Q3 2018 | $869,715,000 | +26.2% | 5,384,899 | +3.3% | 0.03% | +17.2% |
| Q2 2018 | $689,173,000 | +80.5% | 5,213,900 | +1.2% | 0.03% | +70.6% |
| Q1 2018 | $381,828,000 | +35.1% | 5,153,577 | +1.4% | 0.02% | +41.7% |
| Q4 2017 | $282,711,000 | +26.3% | 5,081,058 | +2.9% | 0.01% | +20.0% |
| Q3 2017 | $223,888,000 | +55.9% | 4,935,783 | +15.9% | 0.01% | +42.9% |
| Q2 2017 | $143,572,000 | +18.4% | 4,259,029 | +4.0% | 0.01% | +16.7% |
| Q1 2017 | $121,256,000 | +12.8% | 4,096,486 | +4.5% | 0.01% | 0.0% |
| Q4 2016 | $107,513,000 | -52.4% | 3,919,520 | +6.5% | 0.01% | -53.8% |
| Q3 2016 | $226,009,000 | +281.6% | 3,680,345 | +18.5% | 0.01% | +225.0% |
| Q2 2016 | $59,227,000 | +3.1% | 3,105,816 | +5.5% | 0.00% | 0.0% |
| Q1 2016 | $57,468,000 | -47.6% | 2,944,026 | +3.7% | 0.00% | -42.9% |
| Q4 2015 | $109,573,000 | +32.7% | 2,840,129 | +10.4% | 0.01% | +133.3% |
| Q3 2015 | $82,574,000 | +8.4% | 2,571,591 | +2.8% | 0.00% | -40.0% |
| Q2 2015 | $76,142,000 | +136.6% | 2,502,173 | +3.3% | 0.01% | +150.0% |
| Q1 2015 | $32,182,000 | -2.9% | 2,423,410 | +5.8% | 0.00% | 0.0% |
| Q4 2014 | $33,147,000 | -28.8% | 2,290,714 | +3.8% | 0.00% | -50.0% |
| Q3 2014 | $46,584,000 | -29.9% | 2,207,753 | -1.0% | 0.00% | -20.0% |
| Q2 2014 | $66,430,000 | +31.4% | 2,229,951 | +6.0% | 0.01% | +25.0% |
| Q1 2014 | $50,558,000 | +20.4% | 2,103,931 | +2.1% | 0.00% | 0.0% |
| Q4 2013 | $41,990,000 | -48.8% | 2,061,338 | +18.8% | 0.00% | -50.0% |
| Q3 2013 | $81,943,000 | +34.0% | 1,734,963 | +8.0% | 0.01% | +33.3% |
| Q2 2013 | $61,147,000 | – | 1,606,996 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
| Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
| Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
| Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
| Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
| Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
| ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
| Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
| Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
| GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |